Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment

Neurological Sciences

Volumn 37, Issue 11, 2016, Pages 1807-1813

  Xiao, Libin ^a   Pan, Yougui ^a   Zhang, Xiaolong ^a   Hu, Yong ^a   Cai, Li ^a   Nie, Zhiyu ^a   Pan, Lizhen ^a   Li, Bing ^a   He, Yijing ^a   Jin, Lingjing ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Botulinum toxin A; Facial asymmetry; Hemifacial spasm

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DETERIORATION; FACE ASYMMETRY; FEMALE; FOLLOW UP; HEMIFACIAL SPASM; HUMAN; MALE; MOTOR DYSFUNCTION ASSESSMENT; PROSPECTIVE STUDY; SOCIAL LIFE; SYMMETRY SCALE FOR HEMIFACIAL SPASM; SYNKINESIS; VOLUNTARY MOVEMENT; AGED; DRUG EFFECTS; FACE; FACE MUSCLE; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY;

ADULT; AGED; BOTULINUM TOXINS, TYPE A; FACE; FACIAL MUSCLES; FEMALE; FOLLOW-UP STUDIES; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84978628258     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-016-2670-2     Document Type: Article

References (35)

1. Wang A, Jankovic J (1998) Hemifacial spasm: clinical findings and treatment. Muscle Nerve 21(12):1740–1747
2. Chaudhry N, Srivastava A, Joshi L (2015) Hemifacial spasm: the past, present and future. J Neurol Sci 356(1–2):27–31. doi:10.1016/j.jns.2015.06.032
3. Sorgun MH, Yilmaz R, Akin YA, Mercan FN, Akbostanci MC (2015) Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. J Clin Neurosci 22(8):1319–1325. doi:10.1016/j.jocn.2015.02.032
4. Rudzinska M, Wojcik M, Szczudlik A (2010) Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy. J Neural Transm 117(6):765–772. doi:10.1007/s00702-010-0416-5
5. Park YC, Lim JK, Lee DK, Yi SD (1993) Botulinum a toxin treatment of hemifacial spasm and blepharospasm. J Korean Med Sci 8(5):334–340
6. Kwan MC, Ko KF, Chan TP, Chan YW (1998) Treatment of dystonia with botulinum A toxin: a retrospective study of 170 patients. Hong Kong Med J = Xianggang yi xue za zhi/Hong Kong Academy of Medicine 4(3):279–282
7. Tan EK, Fook-Chong S, Lum SY, Lim E (2004) Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 219(1–2):151–155. doi:10.1016/j.jns.2004.01.010
8. Zafeiriou DI, Mauromatis IV, Hatjisevastou HK, Bostantjopoulou MC, Kontopoulos EE (1997) Benign congenital hemifacial spasm. Pediatr Neurol 17(2):174–176
9. Ross BR, Fradet G, Nedzelski JM (1994) Development of a sensitive clinical facial grading system. Eur Arch Oto-rhino-laryngology 114(3):380–386
10. Chundury RV, D’Angelo AS, Couch SM, Holds JB (2015) Subjective and objective measures in the treatment of hemifacial spasm with OnabotulinumtoxinA. Ophthalmic Plast Reconstr Surg. doi:10.1097/IOP.0000000000000443
11. Kayhan FT, Zurakowski D, Rauch SD (2000) Toronto facial grading system: interobserver reliability. Otolaryngology-Head Neck Surg 122(2):212–215
12. Ross BG, Fradet G, Nedzelski JM (1996) Development of a sensitive clinical facial grading system. Otolaryngology-Head Neck Surg 114(3):380–386
13. Kanerva M, Poussa T, Pitkaranta A (2006) Sunnybrook and House-Brackmann facial grading systems: intrarater repeatability and interrater agreement. Otolaryngology-Head Neck Surg 135(6):865–871. doi:10.1016/j.otohns.2006.05.748
14. Colosimo C, Bologna M, Lamberti S, Avanzino L, Marinelli L, Fabbrini G, Abbruzzese G, Defazio G, Berardelli A (2006) A comparative study of primary and secondary hemifacial spasm. Arch Neurol 63(3):441–444. doi:10.1001/archneur.63.3.441
15. Tang X, Wan X (2000) Comparison of Botox with a Chinese type A botulinum toxin. Chin Med J 113(9):794–798
16. Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD (2007) A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol 30(1):39–42. doi:10.1097/01.WNF.0000236771.77021.3C
17. Quagliato EM, Carelli EF, Viana MA (2010) Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 33(1):27–31. doi:10.1097/WNF.0b013e3181c46f61
18. Wu CJ, Shen JH, Chen Y, Lian YJ (2011) Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm. Turkish Neurosurg 21(4):625–629. doi:10.5137/1019-5149.JTN.4524-11.1
19. Fujimura T, Hotta M (2012) The preliminary study of the relationship between facial movements and wrinkle formation. Skin Res Technol 18(2):219–224. doi:10.1111/j.1600-0846.2011.00557.x
20. Tiryaki T, Ciloglu NS (2007) Eyebrow asymmetry: definition and symmetrical correction using botulinum toxin A. Aesthetic Surg J Am Soc Aesthetic Plastic Surg 27(5):513–517. doi:10.1016/j.asj.2007.06.005
21. Koch RJ, Troell RJ, Goode RL (1997) Contemporary management of the aging brow and forehead. Laryngoscope 107(6):710–715
22. Isse NG (1994) Endoscopic facial rejuvenation: endoforehead, the functional lift. Case reports. Aesthetic Plastic Surg 18(1):21–29
23. Campos-Benitez M, Kaufmann AM (2008) Neurovascular compression findings in hemifacial spasm. J Neurosurg 109(3):416–420. doi:10.3171/JNS/2008/109/9/0416
24. Oh CH, Shim YS, Park H, Kim EY (2015) A case of hemifacial spasm caused by an artery passing through the facial nerve. J Korean Neurosurg Soc 57(3):221–224. doi:10.3340/jkns.2015.57.3.221
25. Saybel A, Artemenko A, Nikitin S, Kurenkov A (2015) A prospective, neurophysiologic comparative study to assess the efficacy and duration of effect of incobotulinumtoxinA and abobotulinumtoxinA in the treatment of crow’s feet. J Drugs Dermatol 14(11):1291–1296
26. Sneath J, Humphrey S, Carruthers A, Carruthers J (2015) Injecting botulinum toxin at different depths is not effective for the correction of eyebrow asymmetry. Dermatol Surg 41(Suppl 1):S82–S87. doi:10.1097/DSS.0000000000000159
27. Couch SM, Chundury RV, Holds JB (2014) Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox). Ophthalmic Plast Reconstr Surg 30(3):246–250. doi:10.1097/IOP.0000000000000086
28. Armstrong MW, Mountain RE, Murray JA (1996) Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy. Clin Otolaryngol Allied Sci 21(1):15–20
29. Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M (2010) Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil 32(17):1414–1418. doi:10.3109/09638280903514697
30. Bentsianov B, Zalvan C, Blitzer A (2004) Noncosmetic uses of botulinum toxin. Clin Dermatol 22(1):82–88. doi:10.1016/j.clindermatol.2003.12.030
31. Atassi MZ (2004) Basic immunological aspects of botulinum toxin therapy. Mov Disord 19(Suppl 8):S68–S84. doi:10.1002/mds.20020
32. Muhlbauer W, Holm C (1998) Eyebrow asymmetry: ways of correction. Aesthetic Plast Surg 22(5):366–371
33. Pennock JD, Johnson PC, Manders EK, VanSwearingen JM (1999) Relationship between muscle activity of the frontalis and the associated brow displacement. Plastic Reconstr Surg 104(6):1789–1797 (discussion 1798–1789)
34. Cannon PS, MacKenzie KR, Cook AE, Leatherbarrow B (2010) Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm. Clin Exp Ophthalmol 38(7):688–691. doi:10.1111/j.1442-9071.2010.02303.x
35. Borodic GE, Cheney M, McKenna M (1992) Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry. Plastic Reconstr Surg 90(6):972–977 (discussion 978–979)